Development and evaluation of a survey of gout patients concerning their knowledge about gout

Journal of Clinical Rheumatology

Volumn 17, Issue 5, 2011, Pages 242-248

  Zhang, Li Yun ^a,b   Schumacher, H Ralph ^b   Su, Hou Heng ^c   Lie, Dai ^d   Dinnella, Janet ^b   Baker, Joshua F ^b   Von Feldt, Joan M ^b  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c QINGDAO MUNICIPAL HOSPITAL   (China)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

gout; patient's knowledge; questionnaire; survey

Indexed keywords

URIC ACID;

ADULT; AGED; EVALUATION; FEMALE; GOUT; HUMAN; INTERNAL CONSISTENCY; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT EDUCATION; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; URIC ACID BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CHINA; DATA COLLECTION; FEMALE; GOUT; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HOSPITALS, VETERANS; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PATIENT PARTICIPATION; QUESTIONNAIRES; UNITED STATES;

EID: 80051801021     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e318228b4e2     Document Type: Review

References (32)

1. Chang HY, Pan WH, Yeh WT, et al. Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-1996). J Rheumatol. 2001;28:1640-1646.
2. Mikuls TR, Farrar JT, Bilker WB, et al. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis. 2005;64:267-272. (Pubitemid 40197509)
3. Chang CJ. Gout and gouty arthritis. Chin Med J. 1959;78:214-219.
4. Yang XY, Tang FL, Yin PD. The trend of proportion among inpatients with gout in 21 hospitals during the past 15 years. Zhonghua Liu Xing Bing Xue Za Zhi. 1996;17:10-12.
5. Wang Q, Chen R, Du L, et al. An epidemiological and clinical study of primary gout. Zhonghua Nei Ke Za Zhi. 2001;40:313-315.
6. Zeng Q, Wang Q, Chen R, et al. Primary gout in Shantou: a clinical and epidemiological study. Chin Med J Engl. 2003;116:66-69. (Pubitemid 36432725)
7. Wigley RD, Zhang NZ, Zeng QY, et al. Rheumatic diseases in China: ILAR-China study comparing the prevalence of rheumatic symptoms in northern and southern rural populations. J Rheumatol. 1994;21:1484-1490. (Pubitemid 24261533)
8. Zeng Q, Huang S, Chen R. 10-year epidemiological study on rheumatic diseases in Shantou area. Zhonghua Nei Ke Za Zhi. 1997;36:193-197.
9. Dai SM, Han XH, Zhao DB, et al. Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study. J Rheumatol. 2003;30:2245-2251.
10. Wortmann RL, Ryan LM. Management of crystal-induced arthropathies. In: Wortmann RL, Schumacher HR Jr, Becker MA, et al, eds. Crystal Induced Arthropathies: Gout, Pseudogout and Apatite-Associated Syndromes. New York: Taylor & Francis; 2006:321-340.
11. Becker MA, Chohan S. We can make gout management more successful now. Curr Opin Rheumatol. 2008;20:167-172. (Pubitemid 351339888)
12. Schlesinger N, Schumacher HR Jr. Gout: can management be improved? Curr Opin Rheumatol. 2001;13:240-244. (Pubitemid 32430079)
13. Vazquez-Mellado J, Cruz J, Guzman S, et al. Severe tophaceous gout: characterization of low socioeconomic level patients from Mexico. Clin Exp Rheum. 2006;24:233-238. (Pubitemid 44151140)
14. Baker JF, Schumacher HR. Update on gout and hyperuricemia. Int J Clin Pract. 2010;64:371-377.
15. Chen LX, Schumacher HR. Gout: an evidence-based review. J Clin Rheumatol. 2008;14(5 suppl):S55-S62.
16. Schumacher HR Jr, Chen LX. The practical management of gout. Cleve Clin J Med. 2008;75(suppl 5):S22-S25.
17. Chen LX, Schumacher HR. Gout: can we create an evidence-based systematic approach to diagnosis and management? Best Pract Res Clin Rheumatol. 2006;20:673-684. (Pubitemid 44354567)
18. Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20:895-900.
19. Malik A, Schumacher HR, Dinnella JE, et al. Clinical diagnostic criteria for gout: comparison with the gold standard of synovial fluid crystal analysis. J Clin Rheumatol. 2009;15:22-24.
20. Zhang W, Doherty M, Bardin T, et al. EULAR evidence bases recommendations for gout. Part II: management: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65:1312-1324. (Pubitemid 44620440)
21. Murphy-Bielicki B, Schumacher HR. How does patient education affect gout? Clin Rheum Pract. 1984;2:77-80.
22. Fang W, Zeng X, Li M, et al. The management of gout at an academic healthcare center in Beijing: a physician survey. J Rheumatol. 2006;33:2041-2049. (Pubitemid 44571880)
23. Zhang W, Doherty M, Pascual E, et al. EULAR evidence based recommendations for gout. Part I: diagnosis: report of a task force of the Standing committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65:1301-1311. (Pubitemid 44641591)
24. Pascual E, Battle-Gualdo E, Martinez A, et al. Synovial fluid analysis for intercritical gout. Ann Intern Med. 1999;131:756-759. (Pubitemid 29531985)
25. Schumacher HR Jr, Sieck MS, Rothfuss S, et al. Reproducibility of synovial fluid analyses: a study among four laboratories. Arthritis Rheum. 1986;29:770-774. (Pubitemid 16094154)
26. McCarthy GM, Barthelemy CR, Veum JA, et al. Influence of antihyperuricemic therapy on the clinical and radiographic progression of gout. Arthritis Rheum. 1991;34:1489-1494.
27. Perez-Ruiz F, Calabozo M, Pijoan JI, et al. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum. 2002;47:355-360.
28. Li-Yu J, Clayburne G, Sieck M, et al. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol. 2001;28:577-580. (Pubitemid 32202663)
29. Ogdie AR, Hock S, Dunham J, et al. A roadmap for education to improve the quality of care in gout. Curr Opin Rheumatol. 2010;22:173-180.
30. Emmerson BT. The management of gout. N Engl J Med. 1996;334:445-451. (Pubitemid 126528536)
31. Bull PW, Scott JT. Intermittent control of hyperuricemia in the treatment of gout. J Rheumatol. 1989;16:1246-1248. (Pubitemid 19260116)
32. van Lieshout-Zuidema MF, Breedveld FC. Withdrawal of longterm antihyperuricemic therapy in tophaceous gout. J Rheumatol. 1993;20:1383-1385. (Pubitemid 23310995)